These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4296871)

  • 41. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 42. The safety test for poliomyelitis vaccine. III. Comparative sensitivity of rhesus and vervet monkeys to poliovirus.
    VAN HOOSIER GL; BARON S; KIRSCHSTEIN RL; ABINANTI FR
    Am J Hyg; 1962 Jan; 75():86-9. PubMed ID: 13924586
    [No Abstract]   [Full Text] [Related]  

  • 43. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
    Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 46. [Several virologic and biochemical aspects of vaccination with antipoliomyelitis vaccine. Characteristics of intracellular virus-specific structures].
    Sadogurskaia EM; Gorshunova LP; Kiselev FL
    Vopr Virusol; 1977; (2):189-92. PubMed ID: 197714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Topography and morphology of intracerebral traumatic foci in Macaca mulatta monkeys (Rheusu)].
    Osetowska E; Taraszewska A
    Neuropatol Pol; 1967; 5(2):235-57. PubMed ID: 6046261
    [No Abstract]   [Full Text] [Related]  

  • 48. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-to-cell spread of poliovirus in the spinal cord of bonnet monkeys (Macaca radiata).
    Ponnuraj EM; John TJ; Levin MJ; Simoes EA
    J Gen Virol; 1998 Oct; 79 ( Pt 10)():2393-403. PubMed ID: 9780044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.
    Simon J; Vonka V; Janda Z
    Arch Gesamte Virusforsch; 1965; 15(5):681-9. PubMed ID: 4285635
    [No Abstract]   [Full Text] [Related]  

  • 51. A collaborative study of the histopathological evaluation of the WHO neurovirulence test for poliovirus vaccines.
    Wood DJ; Heath AB; Marsden SA
    Biologicals; 1994 Mar; 22(1):45-51. PubMed ID: 8068313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential susceptibility of transgenic PVR Tg-mice to poliovirus strains with varying neurovirulence in relation with monkeys.
    Arya SC
    Biologicals; 1995 Jun; 23(2):191. PubMed ID: 7546663
    [No Abstract]   [Full Text] [Related]  

  • 53. Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV
    Acta Virol; 1968 May; 12(3):193-202. PubMed ID: 4385148
    [No Abstract]   [Full Text] [Related]  

  • 54. Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV; Sokolova IS; Alpatova GA
    Arch Gesamte Virusforsch; 1971; 33(3):259-70. PubMed ID: 4329636
    [No Abstract]   [Full Text] [Related]  

  • 55. Different susceptibilities to attenuated poliovirus of cynomolgus monkeys from the Philippines and other Southeast Asian countries.
    Chino F; Eto K; Ohkawa T; Muto T; Komatsu T
    Jpn J Med Sci Biol; 1992 Feb; 45(1):9-17. PubMed ID: 1640648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of 2-phenoxyethanol on potency of Sabin inactivated poliomyelitis vaccine and its safety].
    Bian CX; Jiang SD; Yang JY; Sun MB; Xie MX; Zhang XW; Liao GY; Li WD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):44-6. PubMed ID: 17429533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines.
    Hilleman MR
    Dev Biol Stand; 1998; 94():183-90. PubMed ID: 9776239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [COMPARATIVE STUDY OF THE PATHOGENICITY OF INFECTIOUS RNA AND NATIVE POLIOMYELITIS VIRUS FOR MONKEYS AND MICE].
    GENDON IZ; AMCHENKOVA AM
    Arkh Patol; 1963; 25():38-45. PubMed ID: 14107033
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 60. Neurovirulence.
    Wood D
    Dev Biol Stand; 1999; 101():127-9. PubMed ID: 10566785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.